EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy

Delian Zhou iD, Xiaojian Zhu, Yi Xiao

Cancer Medicine · 2024

DOI: 10.1002/cam4.7375 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2024. Verfasst von Delian Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, Tumor Microenvironment. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor T‐cell (CAR‐T) therapy is becoming an effective technique for the treatment of patients with relapsed/refractory hematologic malignancies. After analyzing patients with tumor progression and sustained remission after CAR‐T cell therapy, many factors were found to be associated with the efficacy of CAR‐T therapy. This paper reviews the factors affecting the effect of CAR‐T such as tumor characteristics, tumor microenvironment and immune function of patients, CAR‐T cell structure, construction method and in vivo expansion values, lymphodepletion chemotherapy, and previous treatment, and provides a preliminary outlook on the corresponding therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenImmunotherapy, AdoptiveTumor MicroenvironmentHumansT-LymphocytesHematologic NeoplasmsTreatment OutcomeReceptors, Antigen, T-CellAnimals

Stichwörter der Autor:innen

chimeric antigen receptor T‐celllymphodepletion chemotherapytherapeutic effect

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

ORCID-Profile: Delian Zhou

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhou, D., Zhu, X., & Xiao, Y. (2024). Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy. Cancer Medicine. https://doi.org/10.1002/cam4.7375

Vancouver

Zhou D, Zhu X, Xiao Y. Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy. Cancer Medicine. 2024. doi:10.1002/cam4.7375

BibTeX
@article{Zhou2024,
  author = {Zhou, Delian and Zhu, Xiaojian and Xiao, Yi},
  title = {Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7375}
}
Kostenlos starten →